Depression in Parkinson’s disease: Health risks, etiology, and treatment options
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Depression is found in about 30%-40% of all patients with Parkinson's disease (PD), but only a small percentage (about 20%) receive treatment. As a consequence, many PD patients suffer with reduced health-related quality of life. To address quality of life in depressed PD patients, we reviewed the literature on the health correlates of depression in PD (eg, cognitive function), etiology of depression in PD, and treatment options (ie, antidepressants, electroconvulsive therapy, and psychotherapy). The current review is unique in its focus on psychosocial aspects, as well as neuropathological factors, of depression in PD. Overall, we conclude that neurochemical (eg, serotonin) and psychosocial factors (eg, coping style, self-esteem, and social support) contribute to the affective disturbances found in this neuropsychiatric population. Therefore, we recommend that a multidisciplinary (eg, pharmacotherapeutic, psychoeducational, and/or psychotherapeutic) approach to treatment be taken with depressed PD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262 · cited 2×
“These fi ndings support the biological basis of depression in PD (Hornykiewicz 1982; Cummings 1993) and that SSRIs, such as citalopram, might provide salutary health benefi ts to depressed and non-depressed PD patients.”
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995) · Quality of Life Research · doi:10.1007/bf02260863 · Cited by 1,204 · cited 2×
“Briefl y, the PDQ-39 is a PD-specifi c, HRQL questionnaire that consists of eight health dimensions – mobility, activities of daily living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort (Peto et al 1995).”
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease
Mayberg, H. S., Starkstein, S. E., Sadzot, B., Preziosi, T., Andrezejewski, P. L., Dannals, R. F., Wagner, H. N., & Robinson, R. G. (1990) · Annals of Neurology · doi:10.1002/ana.410280111 · Cited by 412
Psychosocial correlates of breast cancer and its treatments.
Meyerowitz, B. E. (1980) · Psychological Bulletin · doi:10.1037//0033-2909.87.1.108 · Cited by 331
What contributes to depression in Parkinson's disease?
SCHRAG, A., JAHANSHAHI, M., & QUINN, N. P. (2001) · Psychological Medicine · doi:10.1017/s0033291799003141 · Cited by 242
Antidepressant studies in Parkinson's disease: A review and meta‐analysis
Weintraub, D., Morales, K. H., Moberg, P. J., Bilker, W. B., Balderston, C., Duda, J. E., Katz, I. R., & Stern, M. B. (2005) · Movement Disorders · doi:10.1002/mds.20555 · Cited by 191 · cited 2×
“A meta-analysis conducted in Parkinson’s disease (Weintraub et al 2005) examined the effects of antidepressants on PD-related depression and obtained a large effect size for depression outcomes in both the antidepressant ( d = 1.34) and placebo control group ( d = 1.19).”
InfluentialHobson, P. (1999) · Age and Ageing · doi:10.1093/ageing/28.4.341 · Cited by 152
Cited by
Depression and Parkinson’s Disease: Current Knowledge
Marsh, L. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0409-5 · Cited by 404
Troeung, L., Egan, S. J., & Gasson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079510 · Cited by 132
“Despite this, the majority of cases of depressive and anxiety disorders in PD are not effectively managed, and only an estimated 20% of people with PD experiencing depressive and/or anxiety complications receive some form of professional treatment [5].”
BackgroundRemote delivery of psychological interventions for Parkinson's disease.
Swalwell, C., Pachana, N. A., & Dissanayaka, N. N. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218000340 · Cited by 87
“Many PD patients, however, do not receive mental health treatment (Frisina et al., 2008; Dobkin et al., 2013), given their significant mobility impairments, a lack of available services locally (and a high prevalence of rural and remote PD patients), and 1784 C. Swalwell et al. transportation…”
BackgroundClinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease
Pachana, N. A., Egan, S. J., Laidlaw, K., Dissanayaka, N., Byrne, G. J., Brockman, S., Marsh, R., & Starkstein, S. (2013) · Movement Disorders · doi:10.1002/mds.25689 · Cited by 82
Cognitive Behavioral Therapy for Depression and Anxiety in Parkinson's Disease: A Clinical Review
Armento, M. E. A., Stanley, M. A., Marsh, L., Kunik, M. E., York, M. K., Bush, A. L., & Calleo, J. S. (2012) · Journal of Parkinson's Disease · doi:10.3233/jpd-2012-12080 · Cited by 49
Metadata
- Authors
- Borod, J.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2008-03
- Volume
- 4
- Issue
- 1
- Pages
- 81
- ISSN
- 1176-6328 (ISSN-L)
- OpenAlex
- W2026141431
- Cited by
- 82
- References
- 8
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression in Parkinson’s disease: Health risks, etiology, and treatment options. https://app.cochat.ai/papers/10.2147/ndt.s1453
- The paper
- Borod, J. (2008). Depression in Parkinson’s disease: Health risks, etiology, and treatment options. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s1453
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.